HKSE - Delayed Quote HKD
Shanghai Henlius Biotech, Inc. (2696.HK)
38.450
+0.750
+(1.99%)
As of 2:53:53 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,241,887
1,241,887
1,047,921
981,620
90,392
Investing Cash Flow
-909,965
-909,965
-1,004,437
-1,358,731
-1,681,254
Financing Cash Flow
-643,367
-643,367
144,431
858,016
648,302
End Cash Position
571,401
571,401
867,663
673,476
154,982
Capital Expenditure
-837,206
-837,206
-1,011,444
-1,365,292
-1,131,193
Issuance of Capital Stock
2,949,753
--
--
--
--
Issuance of Debt
2,673,958
2,673,958
2,511,759
2,859,028
2,095,706
Repayment of Debt
-3,081,685
-3,081,685
-2,147,093
-1,785,465
-1,295,651
Free Cash Flow
404,681
404,681
36,477
-383,672
-1,040,801
12/31/2021 - 9/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9995.HK RemeGen Co., Ltd.
39.200
+11.05%
2171.HK CARsgen Therapeutics Holdings Limited
15.480
+3.34%
9966.HK Alphamab Oncology
6.960
-4.92%
2157.HK Lepu Biopharma Co., Ltd.
4.320
+3.10%
2142.HK HBM Holdings Limited
7.930
+1.02%
1952.HK Everest Medicines Limited
46.300
-6.84%
1530.HK 3SBIO
13.340
+4.22%
6622.HK Zhaoke Ophthalmology Limited
1.650
-0.60%
9606.HK Duality Biotherapeutics, Inc.
219.800
+0.55%
6660.HK AIM Vaccine Co., Ltd.
3.390
-0.29%